114.64
0.61%
0.695
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Ligand Pharmaceuticals Inc Azioni (LGND) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
10.24%
30.98
|
28.10 | 32.87 | 26.37 | 43.98 |
Operating Expenses
|
11.03%
27.99
|
31.46 | 29.79 | 28.35 | 29.77 |
Interest Income/Expense |
7.63%
0.141
|
0.131 | 0.001 | 0.284 | 0.24 |
Benefits Costs and Expenses |
849.45%
-82.47
|
11.00 | 45.01 | 23.20 | -11.56 |
Costs And Expenses |
849.45%
-82.47
|
11.00 | 45.01 | 23.20 | -11.56 |
Operating Income/Loss |
188.98%
2.988
|
-3.358 | 3.078 | -1.983 | 14.21 |
Nonoperating Income/Loss |
440.01%
110.46
|
20.45 | -15.22 | 5.154 | 41.33 |
Income/Loss Before Equity Method Investments |
115.80
|
- | - | - | - |
Income/Loss From Equity Method Investments |
-2.352
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
563.55%
113.45
|
17.10 | -12.14 | 3.171 | 55.54 |
Income Tax Expense/Benefit |
2,603%
27.31
|
-1.091 | -1.871 | 0.881 | 11.92 |
Income/Loss From Continuing Operations After Tax |
373.60%
86.14
|
18.19 | -10.27 | 2.29 | 43.61 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | -1.665 |
Net Income/Loss
|
373.60%
86.14
|
18.19 | -10.27 | 2.29 | 41.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
31,009%
17.73
|
0.057 | 17.38 | 17.28 | 17.06 |
Diluted Average Shares |
67,219%
18.12
|
-0.027 | 17.38 | 17.73 | 17.97 |
Basic Earnings Per Share |
362.86%
4.86
|
1.05 | -0.59 | 0.13 | 2.46 |
Diluted Earnings Per Share |
361.17%
4.75
|
1.03 | -0.59 | 0.13 | 2.33 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):